Large-Scale Production and Structural and Biophysical Characterizations of the Human Hepatitis B Virus Polymerase
Open accessThe DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Abstract
Hepatitis B virus (HBV) is a major human pathogen that causes serious liver disease and 600,000 deaths annually. Approved therapies for treating chronic HBV infections usually target the multifunctional viral polymerase (hPOL). Unfortunately, these therapies—broad-spectrum antivirals—are not general cures, have side effects, and cause viral resistance. While hPOL remains an attractive therapeutic target, it is notoriously difficult to express and purify in a soluble form at yields appropriate for structural studies. Thus, no empirical structural data exist for hPOL, and this impedes medicinal chemistry and rational lead discovery efforts targeting HBV. Here, we present an efficient strategy to overexpress recombinant hPOL domains in Escherichia coli , purifying them at high yield and solving their known aggregation tendencies. This allowed us to perform the first structural and biophysical characterizations of hPOL domains. Apo-hPOL domains adopt mainly α-helical structures with small amounts of β-sheet structures. Our recombinant material exhibited metal-dependent, reverse transcriptase activity in vitro , with metal binding modulating the hPOL structure. Calcomine orange 2RS, a small molecule that inhibits duck HBV POL activity, also inhibited the in vitro priming activity of recombinant hPOL. Our work paves the way for structural and biophysical characterizations of hPOL and should facilitate high-throughput lead discovery for HBV. IMPORTANCE The viral polymerase from human hepatitis B virus (hPOL) is a well-validated therapeutic target. However, recombinant hPOL has a well-deserved reputation for being extremely difficult to express in a soluble, active form in yields appropriate to the structural studies that usually play an important role in drug discovery programs. This has hindered the development of much-needed new antivirals for HBV. However, we have solved this problem and report here procedures for expressing recombinant hPOL domains in Escherichia coli and also methods for purifying them in soluble forms that have activity in vitro . We also present the first structural and biophysical characterizations of hPOL. Our work paves the way for new insights into hPOL structure and function, which should assist the discovery of novel antivirals for HBV.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“When combined with ion mobility, a gas phase–based separation, native MS becomes a valuable technique for structural virologists to determine the size and shape of intermediate and mature capsid structures (Figure 2) (25–27).”
From The Impact of Mass Spectrometry–Based Proteomics on Fundamental Discoveries in Virology (2014) · cites this paper as [26]
Citations
Cites
Sreerama, N., & Woody, R. W. (2000) · Analytical Biochemistry · doi:10.1006/abio.2000.4880 · Cited by 2,992 · cited 1×
“Deconvolution of the far-UV CD spectrum suggested apo-TP1–192 contained 31% -helix and 16% -sheet, values that agreed well with the sequence-based structural predictions (32% -helix and 10% -sheet, respectively) (Table 1) (57, 66).”
BackgroundHsp70 chaperones: Cellular functions and molecular mechanism
Mayer, M. P., & Bukau, B. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4464-6 · Cited by 2,865
Rational design of potent sialidase-based inhibitors of influenza virus replication
von Itzstein, M., Wu, W.-Y., Kok, G. B., Pegg, M. S., Dyason, J. C., Jin, B., Van Phan, T., Smythe, M. L., White, H. F., Oliver, S. W., et al. (1993) · Nature · doi:10.1038/363418a0 · Cited by 1,862
Ott, J. J., Stevens, G. A., Groeger, J., & Wiersma, S. T. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.12.116 · Cited by 1,843 · cited 1×
“and causes 600,000 deaths annually (1).”
NPS@: Network Protein Sequence Analysis
Combet, C., Blanchet, C., Geourjon, C., & Deléage, G. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01540-6 · Cited by 1,757 · cited 9×
“tools and hydrophobic cluster analysis (HCA) (57, 58) to help”
BackgroundMethodInfluentialOrigin and evolution of retroelements based upon their reverse transcriptase sequences
Xiong, Y., & Eickbush, T. H. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07536.x · Cited by 1,374
Structure and mechanism of the Hsp90 molecular chaperone machinery
Pearl, L. H., & Prodromou, C. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142738 · Cited by 1,103
Oppenheimer, N. J., & James, T. L. (1989) · Academic Press eBooks · Cited by 820
Molecular Interaction Studies Using Microscale Thermophoresis
Jerabek-Willemsen, M., Wienken, C. J., Braun, D., Baaske, P., & Duhr, S. (2011) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2011.0380 · Cited by 812 · cited 2×
“The differences in normalized fluorescence intensities in the selected data range (gray bars) were used to determine the binding curve shown in panel B (76).”
BackgroundMethodIsothermal Titration Calorimetry of Protein–Protein Interactions
Pierce, M. M., Raman, C. S., & Nall, B. T. (1999) · Methods · doi:10.1006/meth.1999.0852 · Cited by 576
Beck, J. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i1.48 · Cited by 494
Toh, H., Hayashida, H., & Miyata, T. (1983) · Nature · doi:10.1038/305827a0 · Cited by 458
Hepatitis B viruses: Reverse transcription a different way
Nassal, M. (2008) · Virus Research · doi:10.1016/j.virusres.2007.12.024 · Cited by 382 · cited 2×
“During protein-primed initiation of reverse transcription, the enzymatic activity of RT covalently attaches a deoxyribonucleotide to the side chain hydroxyl group of Y63 in TP (8, 13).”
BackgroundNomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region
Stuyver, L. (2001) · Hepatology · doi:10.1053/jhep.2001.22166 · Cited by 382
Koh, Y., Nakata, H., Maeda, K., Ogata, H., Bilcer, G., Devasamudram, T., Kincaid, J. F., Boross, P., Wang, Y.-F., Tie, Y., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3123-3129.2003 · Cited by 367
Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity
Radziwill, G., Tucker, W., & Schaller, H. (1990) · Journal of Virology · doi:10.1128/jvi.64.2.613-620.1990 · Cited by 356 · cited 2×
“Importantly, these studies also revealed the following: (i) the spacer domain is dispensable and not needed for hPOL activity (10); (ii) the TP domain did not need to be part of the same polypeptide chain as RT and RH to mediate protein-priming and elongation activities (and vice versa); (iii) independently expressed…”
BackgroundSmith, D. P., Knapman, T. W., Campuzano, I., Malham, R. W., Berryman, J. T., Radford, S. E., & Ashcroft, A. E. (2009) · European Journal of Mass Spectrometry · doi:10.1255/ejms.947 · Cited by 334
Self-citationHsp90 is required for the activity of a hepatitis B virus reverse transcriptase.
Hu, J., & Seeger, C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1060 · Cited by 323
Mechanisms for regulation of Hsp70 function by Hsp40
Fan, C.-Y., Lee, S., & Cyr, D. M. (2003) · Cell Stress & Chaperones · doi:10.1379/1466-1268(2003)008<0309:mfrohf>2.0.co;2 · Cited by 320
Hu, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.1.59 · Cited by 312
Novel mechanism for reverse transcription in hepatitis B viruses
Wang, G. H., & Seeger, C. (1993) · Journal of Virology · doi:10.1128/jvi.67.11.6507-6512.1993 · Cited by 295
Chaperone-based procedure to increase yields of soluble recombinant proteins produced in E. coli
de Marco, A., Deuerling, E., Mogk, A., Tomoyasu, T., & Bukau, B. (2007) · BMC Biotechnology · doi:10.1186/1472-6750-7-32 · Cited by 289 · cited 1×
“coli cultures prior to induction of RT-RH expression (63), thereby inducing a chaperone response that increased RT-RH303–778 and RT-RH303–783 expression to very high levels ( 40% of total cellular protein), albeit still in an insoluble form (Fig.”
BackgroundHepatitis B virus genetic variability and evolution
Kay, A., & Zoulim, F. (2007) · Virus Research · doi:10.1016/j.virusres.2007.02.021 · Cited by 278
Popot, J.-L., Althoff, T., Bagnard, D., Banères, J.-L., Bazzacco, P., Billon-Denis, E., Catoire, L. J., Champeil, P., Charvolin, D., Cocco, M. J., et al. (2011) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-042910-155219 · Cited by 257 · cited 2×
“While amphipols are typically used to solubilize membrane proteins (64), we demonstrated that they efficiently solubilized recombinant hPOL constructs (Fig.”
BackgroundReverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase
Zoulim, F., & Seeger, C. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.6-13.1994 · Cited by 255
McLaughlin, S. H., Smith, H. W., & Jackson, S. E. (2002) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5245 · Cited by 242 · cited 1×
“was purified as previously reported (55).”
Aspects of native proteins are retained in vacuum
Ruotolo, B. T., & Robinson, C. V. (2006) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2006.08.020 · Cited by 235 · cited 1×
“IMS-MS is a gas-phase technique that allows different polypeptide conformers (and complexes thereof) to be resolved (72, 73), providing they have significantly different mobility through the ion mobility drift cell (arising from their distinct orientationally averaged collision cross-sections [74]).”
BackgroundDarunavir, a conceptually new HIV-1 protease inhibitor for the treatment of drug-resistant HIV
Ghosh, A. K., Dawson, Z. L., & Mitsuya, H. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.09.010 · Cited by 230
Bartenschlager, R., & Schaller, H. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03315.x · Cited by 198
Static light scattering to characterize membrane proteins in detergent solution
Slotboom, D. J., Duurkens, R. H., Olieman, K., & Erkens, G. B. (2008) · Methods · doi:10.1016/j.ymeth.2008.06.012 · Cited by 183 · cited 1×
“In order to determine the oligomeric state of TP1–192, we performed a conjugate analysis, an approach more commonly employed in SEC-MALS studies of membrane proteins embedded within detergent micelles (70).”
MethodRequirement of Heat Shock Protein 90 for Human Hepatitis B Virus Reverse Transcriptase Function
Hu, J., Flores, D., Toft, D., Wang, X., & Nguyen, D. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.13122-13131.2004 · Cited by 181 · cited 2×
“A few laboratories have successfully produced recombinant full-length dPOL, hPOL, or POL “miniproteins” wherein the functionally dispensable spacer region has been removed (13, 16, 17, 26, 27, 36, 37).”
BackgroundHepadnavirus P protein utilizes a tyrosine residue in the TP domain to prime reverse transcription
Weber, M., Bronsema, V, Bartos, H., Bosserhoff, A., Bartenschlager, R., & Schaller, H. (1994) · Journal of Virology · doi:10.1128/jvi.68.5.2994-2999.1994 · Cited by 164
Hepatitis B virus resistance to antiviral drugs: where are we going?
Zoulim, F. (2011) · Liver International · doi:10.1111/j.1478-3231.2010.02399.x · Cited by 147 · cited 2×
“plex and human immunodeficiency viruses) (2, 3).”
BackgroundRaboisson, P., de Kock, H., Rosenquist, Å., Nilsson, M., Oden, L. S., Lin, T., Roue, N., Ivanov, V., Wähling, H., Wickström, K., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.07.088 · Cited by 145
Smith, D. P., Giles, K., Bateman, R. H., Radford, S. E., & Ashcroft, A. E. (2007) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2007.09.017 · Cited by 132 · cited 1×
“IMS-MS is a gas-phase technique that allows different polypeptide conformers (and complexes thereof) to be resolved (72, 73), providing they have significantly different mobility through the ion mobility drift cell (arising from their distinct orientationally averaged collision cross-sections [74]).”
BackgroundSelf-citationMerelo, J. J., Andrade-Navarro, M. A., Prieto, A., & Morán, F. (1994) · Neurocomputing · doi:10.1016/0925-2312(94)90021-3 · Cited by 131
Hepatitis B Virus Replication: Novel Roles for Virus-Host Interactions
Nassal, M. (1999) · Intervirology · doi:10.1159/000024970 · Cited by 123
Lanford, R. E., Notvall, L., & Beames, B. (1995) · Journal of Virology · doi:10.1128/jvi.69.7.4431-4439.1995 · Cited by 117 · cited 1×
“The first nucleotide incorporated into TP has been reported to be G (as shown here), whereas others have shown that T can also be used (shown in lowercase) (17, 31, 46, 87).”
ResultLanford, R. E., Notvall, L., Lee, H., & Beames, B. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.2996-3004.1997 · Cited by 109 · cited 3×
“During protein-primed initiation of reverse transcription, the enzymatic activity of RT covalently attaches a deoxyribonucleotide to the side chain hydroxyl group of Y63 in TP (8, 13).”
BackgroundTavis, J. E., Cheng, X., Hu, Y., Totten, M., Cao, F., Michailidis, E., Aurora, R., Meyers, M. J., Jacobsen, E. J., Parniak, M. A., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003125 · Cited by 106 · cited 2×
“cations preserve reported RH catalytic residues (62) but eliminate”
Hu, J., Toft, D., Anselmo, D., & Wang, X. (2002) · Journal of Virology · doi:10.1128/jvi.76.1.269-279.2002 · Cited by 106 · cited 1×
“To further validate our recombinant TP1–192 and RTRH303–778 constructs, we used them in in vitro reconstitution assays reported to support dPOL- or hPOL-mediated proteinpriming activity (17, 36, 37, 40, 41, 46).”
MethodGohon, Y., Giusti, F., Prata, C. A. H., Charvolin, D., Timmins, P. A., Ebel, C., Tribet, C., & Popot, J. (2006) · Langmuir · doi:10.1021/la052243g · Cited by 102 · cited 1×
“Control experiments, where only NV-10 was injected onto the column, showed that peak II corresponded to NV-10 oligomers that form in solution at the high concentrations employed, as reported for other amphipols (75).”
BackgroundHu, J., & Anselmo, D. (2000) · Journal of Virology · doi:10.1128/jvi.74.24.11447-11455.2000 · Cited by 95 · cited 2×
“To further validate our recombinant TP1–192 and RTRH303–778 constructs, we used them in in vitro reconstitution assays reported to support dPOL- or hPOL-mediated proteinpriming activity (17, 36, 37, 40, 41, 46).”
BackgroundMethodEvidence for activation of the hepatitis B virus polymerase by binding of its RNA template
Tavis, J. E., & Ganem, D. (1996) · Journal of Virology · doi:10.1128/jvi.70.9.5741-5750.1996 · Cited by 95 · cited 1×
“had been reported to facilitate hPOL expression (51, 52).”
BackgroundBeck, J., & Nassal, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301069200 · Cited by 87 · cited 1×
“In this context, we note that addition of Hsc70 and Hsp40 — chaperones that play important roles in initiating reverse transcription in HBV (39, 41)—significantly reduced the in vitro aggregation tendencies of the TP1–192–RT-RH303–778 complex (unpublished data).”
BackgroundHu, J., & Boyer, M. (2006) · Journal of Virology · doi:10.1128/jvi.80.5.2141-2150.2006 · Cited by 87
Alexander, C. G., Jürgens, M. C., Shepherd, D. A., Freund, S. M. V., Ashcroft, A. E., & Ferguson, N. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308846110 · Cited by 85
Self-citationReview of Hepatitis B Therapeutics
Bhattacharya, D., & Thio, C. (2010) · Clinical Infectious Diseases · doi:10.1086/656624 · Cited by 81
Lewellyn, E. B., & Loeb, D. D. (2010) · Journal of Virology · doi:10.1128/jvi.01957-10 · Cited by 81
The Duck Hepatitis B Virus Polymerase Is Activated by Its RNA Packaging Signal, ɛ
Tavis, J. E., Massey, B., & Gong, Y. (1998) · Journal of Virology · doi:10.1128/jvi.72.7.5789-5796.1998 · Cited by 80
Stevens, J. C., Chia, R., Hendriks, W. T., Bros-Facer, V., van Minnen, J., Martin, J. E., Jackson, G. S., Greensmith, L., Schiavo, G., & Fisher, E. M. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009541 · Cited by 78
Kleymann, G. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.2.135 · Cited by 74
Entecavir for the treatment of chronic hepatitis B virus infection
Matthews, S. J. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.02.012 · Cited by 73
Beck, J., & Nassal, M. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6265 · Cited by 72
In Vitro Epsilon RNA-Dependent Protein Priming Activity of Human Hepatitis B Virus Polymerase
Jones, S. A., Boregowda, R. K., Spratt, T. E., & Hu, J.-M. (2012) · Journal of Virology · doi:10.1128/jvi.07137-11 · Cited by 69 · cited 6×
“pected for in vitro protein priming (17, 46).”
BackgroundMethodResultInfluentialStahl, M., Retzlaff, M., Nassal, M., & Beck, J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm628 · Cited by 65 · cited 2×
“To further validate our recombinant TP1–192 and RTRH303–778 constructs, we used them in in vitro reconstitution assays reported to support dPOL- or hPOL-mediated proteinpriming activity (17, 36, 37, 40, 41, 46).”
BackgroundMethodA generalized analysis of hydrophobic and loop clusters within globular protein sequences
Eudes, R., Tuan, K. L., Delettré, J., Mornon, J., & Callebaut, I. (2007) · BMC Structural Biology · doi:10.1186/1472-6807-7-2 · Cited by 57
Stahl, M., Beck, J., & Nassal, M. (2007) · Journal of Virology · doi:10.1128/jvi.01196-07 · Cited by 56
Yin, P. D., Das, D., & Mitsuya, H. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6009-7 · Cited by 53
Lanford, R. E., Kim, Y.-H., Lee, H. H., Notvall, L., & Beames, B. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.1885-1893.1999 · Cited by 52 · cited 3×
“The domain boundaries of hPOL were originally mapped by systematically truncating its N or C termini to determine which constructs retained functional activity in cellular trans-complementation assays (34).”
BackgroundChen, Y., Robinson, W. S., & Marion, P. L. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.5232-5238.1994 · Cited by 52
Beck, J., & Nassal, M. (1997) · Journal of Virology · doi:10.1128/jvi.71.7.4971-4980.1997 · Cited by 51
Beck, J., & Nassal, M. (2001) · Journal of Virology · doi:10.1128/jvi.75.16.7410-7419.2001 · Cited by 49 · cited 2×
“To further validate our recombinant TP1–192 and RTRH303–778 constructs, we used them in in vitro reconstitution assays reported to support dPOL- or hPOL-mediated proteinpriming activity (17, 36, 37, 40, 41, 46).”
BackgroundMethodAntiviral therapies: Focus on hepatitis B reverse transcriptase
Michailidis, E., Kirby, K. A., Hachiya, A., Yoo, W., Hong, S. P., Kim, S.-O., Folk, W. R., & Sarafianos, S. G. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.04.006 · Cited by 47 · cited 2×
“plex and human immunodeficiency viruses) (2, 3).”
BackgroundTsantrizos, Y. S. (2004) · Biopolymers · doi:10.1002/bip.20127 · Cited by 43
Molt cycle–dependent molecular chaperone and polyubiquitin gene expression in lobster
Spees, J. L., Chang, S. A., Mykles, D. L., Snyder, M. J., & Chang, E. S. (2003) · Cell Stress and Chaperones · doi:10.1379/1466-1268(2003)008<0258:mcmcap>2.0.co;2 · Cited by 43
Interaction between Hepatitis B Virus Core Protein and Reverse Transcriptase
Lott, L., Beames, B., Notvall, L., & Lanford, R. E. (2000) · Journal of Virology · doi:10.1128/jvi.74.24.11479-11489.2000 · Cited by 38
Roesler, K. R., & Rao, A. G. (1999) · Protein Engineering Design and Selection · doi:10.1093/protein/12.11.967 · Cited by 38
Protein-Primed Terminal Transferase Activity of Hepatitis B Virus Polymerase
Jones, S. A., & Hu, J. (2013) · Journal of Virology · doi:10.1128/jvi.02786-12 · Cited by 37 · cited 8×
“These data show that the product of the authentic priming reaction was strictly TP dependent but was not strictly epsilon dependent (46).”
BackgroundMethodResultInfluentialHeat Shock Protein 90-Independent Activation of Truncated Hepadnavirus Reverse Transcriptase
Wang, X., Qian, X., Guo, H., & Hu, J. (2003) · Journal of Virology · doi:10.1128/jvi.77.8.4471-4480.2003 · Cited by 37
The hepatitis B virus preS1 domain hijacks host trafficking proteins by motif mimicry
Jürgens, M. C., Vörös, J., Rautureau, G. J. P., Cooper-Shepherd, D. A., Pye, V. E., Muldoon, J., Johnson, C. M., Ashcroft, A. E., Freund, S. M. V., & Ferguson, N. S. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1294 · Cited by 31
Self-citationUrban, M. K., McMillan, D. J., Canning, G., Newell, A., Brown, E. G., MILLS, J. S., & Jupp, R. A. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-5-1121 · Cited by 30 · cited 6×
“9C), as this has been shown to favor protein priming when manganese chloride is in molar excess (31).”
BackgroundResultInfluentialBadtke, M. P., Khan, I., Cao, F., Hu, J., & Tavis, J. E. (2009) · Virology · doi:10.1016/j.virol.2009.04.023 · Cited by 29
Purification of recombinant and endogenous HSP70s
Ménoret, A. (2003) · Methods · doi:10.1016/s1046-2023(03)00180-4 · Cited by 28 · cited 1×
“Purification was carried out as reported elsewhere (53).”
MethodWei, X., & Peterson, D. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32617 · Cited by 27 · cited 2×
“Despite extensive efforts, we have been unable to express RH as an independent domain, or to reproduce others’ reports of this (62, 65, 80), despite using the same E.”
BackgroundResultLi, L., Wan, F., & Hu, J. (2008) · Journal of Virology · doi:10.1128/jvi.02760-07 · Cited by 26 · cited 2×
“The structures of TP and RT-RH were modulated by binding divalent metal cations that modulate hPOL activity (31, 46, 50).”
BackgroundWang, Y., Wen, Y., & Nassal, M. (2012) · Journal of Virology · doi:10.1128/jvi.00816-12 · Cited by 26
Beck, J., & Nassal, M. (2011) · Journal of Virology · doi:10.1128/jvi.00482-11 · Cited by 25 · cited 2×
“Removing TP did not reduce protein labeling, consistent with cryptic priming by RT (42, 43).”
Background[33] Purification of Hsp90 partner proteins Hop/p60, p23, and FKBP52
Büchner, J., Weikl, T., Bügl, H., Pirkl, F., & Bose, S. (1998) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(98)90035-0 · Cited by 23 · cited 1×
“Hop was purified according to reported protocols (54).”
MethodChoi, J., Kim, E. E., Park, Y. I., & Han, Y. S. (2002) · Antiviral Research · doi:10.1016/s0166-3542(02)00023-2 · Cited by 22 · cited 2×
“A few laboratories have successfully produced recombinant full-length dPOL, hPOL, or POL “miniproteins” wherein the functionally dispensable spacer region has been removed (13, 16, 17, 26, 27, 36, 37).”
BackgroundPotenza, N., Salvatore, V., Raimondo, D., Falanga, D., Nobile, V., Peterson, D. L., & Russo, A. (2007) · Protein Expression and Purification · doi:10.1016/j.pep.2007.04.005 · Cited by 18 · cited 1×
“Despite extensive efforts, we have been unable to express RH as an independent domain, or to reproduce others’ reports of this (62, 65, 80), despite using the same E.”
ResultBoregowda, R. K., Lin, L., Zhu, Q., Tian, F., & Hu, J. (2011) · Journal of Virology · doi:10.1128/jvi.00483-11 · Cited by 17 · cited 2×
“Removing TP did not reduce protein labeling, consistent with cryptic priming by RT (42, 43).”
BackgroundExpression of stable hepatitis B viral polymerase associated with GRP94 in E. coli
Kim, S., Shin, H. J., Cho, Y. H., & Rho, H. M. (2000) · Archives of Virology · doi:10.1007/s007050070092 · Cited by 16 · cited 2×
“A few laboratories have successfully produced recombinant full-length dPOL, hPOL, or POL “miniproteins” wherein the functionally dispensable spacer region has been removed (13, 16, 17, 26, 27, 36, 37).”
BackgroundAyola, B., Kanda, P., & Lanford, R. E. (1993) · Virology · doi:10.1006/viro.1993.1270 · Cited by 14
Boregowda, R. K., Adams, C., & Hu, J. (2012) · Journal of Virology · doi:10.1128/jvi.00086-12 · Cited by 14
The Helicase–Primase Complex as a Target for Effective Herpesvirus Antivirals
Field, H. J., & Mickleburgh, I. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5037-5_7 · Cited by 12
Coordinated evolution of the Hepatitis B Virus Polymerase
Campo, D. S., Dimitrova, Z., Lara, J., Purdy, M. A., Thai, H. T. C., Ramachandran, S., Ganova-Raeva, L. M., Zhai, X., Forbi, J. C., Teo, C., et al. (2012) · In Silico Biology · doi:10.3233/isb-2012-0452 · Cited by 8
Expression and purification of a functional human hepatitis B virus polymerase
Yu, Y. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i45.5752 · Cited by 5
Expression of Recombinant HBV Pol Proteins in HepG2 Cells
Cho, G., Na, S.-G., Suh, S.-W., & Jung, G. (2000) · BMB Reports · Cited by 3
Research works printed but not linked: 2
- TheisenA. 2000. Refractive increment data book for polymer and biomolecular scientists. Nottingham University Press, Nottingham, United Kingdom.
- 10.01089/adt.2011.0380 · doi:10.01089/adt.2011.0380
Cited by
Zeisel, M. B., Lucifora, J., Mason, W. S., Sureau, C., Beck, J., Levrero, M., Kann, M., Knolle, P. A., Benkirane, M., Durantel, D., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-308943 · Cited by 256
Königer, C., Wingert, I., Marsmann, M., Rösler, C., Beck, J., & Nassal, M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409986111 · Cited by 239
“bond was sterically shielded; the notorious problems in keeping recombinant P protein soluble (9, 51) support this view.”
BackgroundMenéndez-Arias, L., Álvarez, M., & Pacheco, B. (2014) · Current Opinion in Virology · doi:10.1016/j.coviro.2014.04.005 · Cited by 163
Menéndez-Arias, L., Sebastián-Martín, A., & Álvarez, M. (2017) · Virus Research · doi:10.1016/j.virusres.2016.12.019 · Cited by 123
The Impact of Mass Spectrometry–Based Proteomics on Fundamental Discoveries in Virology
Greco, T. M., Diner, B. A., & Cristea, I. M. (2014) · Annual Review of Virology · doi:10.1146/annurev-virology-031413-085527 · Cited by 67
Metadata
- Authors
- Vörös, J., Urbanek, A., Rautureau, G. J. P., O'Connor, M., Fisher, H. C., Ashcroft, A. E., & Ferguson, N.
- Affiliations
- University College Dublin (IE)
- University of Leeds (GB)
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2014-03
- Volume
- 88
- Issue
- 5
- Pages
- 2584-2599
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC3958071
- OpenAlex
- W2085965763
- Cited by
- 27
- References
- 89
- Citations by year
- 2024: 2 · 2023: 2 · 2022: 2 · 2020: 6 · 2019: 4 · 2018: 1 · 2016: 3 · 2015: 3 · 2014: 4
- FWCI
- 1.50
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Virology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
- Keywords
- hepatitis B virus, viral polymerase, recombinant protein expression, protein purification, protein aggregation, protein structure, reverse transcriptase activity, metal ion binding, calmodulin, calmodulin antagonists, antiviral drug discovery, therapeutic target
- MeSH terms
- Algorithms, Circular Dichroism, Hepatitis B virus, Humans, Models, Molecular, Protein Binding, Recombinant Proteins, Ribonucleoproteins, Mass Spectrometry, Gene Products, pol, Protein Structure, Secondary, Protein Interaction Domains and Motifs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.